Drug Database
Back to search

Belgium· BE-AMP-SAM579342-00

Vaxzevria

A covid-19, viral vector, non-replicating product containing covid-19 vaccine (chadox1-s [recombinant]), registered in Belgium by AstraZeneca. The same ATC class is registered in 3 of our 19 countries.

ATC J07BN02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVaxzevriaATCJ07BN02REGISTER NO.BE-AMP-SAM579342-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about covid-19 vaccine (chadox1-s [recombinant])Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, viral vector, non-replicating is registered in 3 of 19 countries.

Countries holding a registration under ATC J07BN02 (covid-19, viral vector, non-replicating), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose
Search covid-19, viral vector, non-replicating products by name

Covid-19, viral vector, non-replicating · ATC J07BN02

3 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
COVID-19 Vaccine (ChAdOx1-S [Recombinant])
Manufacturer
AstraZeneca
Country
Belgium (BE)
ATC code
J07BN02
ATC class
Covid-19, viral vector, non-replicating
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4314894

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Covid-19, viral vector, non-replicating in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All covid-19, viral vector, non-replicating products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df18f047-d03b-42cc-8491-14dfe245daa5
GET /v1/drugs/df18f047-d03b-42cc-8491-14dfe245daa5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Vaxzevria",
  "name_fr": "Vaxzevria",
  "name_nl": "Vaxzevria",
  "amp_code": "SAM579342-00",
  "strengths": [
    "2.0000",
    "2.0000"
  ],
  "pack_count": 2,
  "substances": [
    "COVID-19 Vaccine (ChAdOx1-S [Recombinant])",
    "Disodium Edetate Dihydrate",
    "Ethanol",
    "Sodium Chloride",
    "Sucrose",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Covid-19, Viral Vector, Non-replicating",
  "authorisation_numbers": [
    "EU/1/21/1529/001",
    "EU/1/21/1529/002"
  ]
}
API referenceMCP serverPlans

See everything about covid-19, viral vector, non-replicating.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console